SIG.AX · SIGMA HEALTHCARE LIMITED
Australia · RS rating 74 · As of 2026-10-14
| Price | 2.81 AUD |
|---|---|
| 1-day change | +3.3% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 85 / 50 / 64 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 33 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +11.1% |
| Market cap (USD) | $21.5B |